Elekta (EKTA-B.ST) announced today that its latest solution for proton therapy, Monaco®* treatment planning for protons, has received 510(k) clearance from the U.S. Food and Drug Administration.
Concord Medical Services Holdings Limited is pleased to announce that on June 29, 2017 its subsidiary, Guangzhou Concord Cancer Hospital Ltd., entered into an agreement with Varian Medical Systems Particle Therapy